Clinical Trial Update: A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 long-term trial comparing liraglutide to glimepiride, both added to metformin, in patients with Type 2 Diabetes has been withdrawn. The study aimed to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Victoza (Liraglutide)

Snippet

Sponsor: Fundación Fernández-Cruz | Conditions: Type 2 Diabetes | Phase 4 | Status: WITHDRAWN